Skip to main content

Table 2 Prevalence of FVIII inhibitors between Severe and Moderate Hemophilia Patients

From: Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?

Inhibitors F VIII inhibitor positive
N (%)
F VIII inhibitor negative
N (%)
total
Degree
Severe HA
N (%)
16 (22) 56 (78) 72
Moderate HA
N (%)
5 (10) 43 (90) 48
Total 21 99 120
Test 2.62
P value 0.105
  1. HA hemophilia A, N number, % percent, ***highly significant, test chi-square